Contact

  • English
  • Español
  • Analysis

    Policy Brief n°3: Health and Development

    Publié le 02/09/2019.

    This Policy Brief summarises the important progress made on global health in recent decades, before examining the unfinished agenda of the Millennium Development Goals on health, and the challenges for achieving the health objectives of the Sustainable Development Goals, and finally how international health aid is evolving and the threats this investment faces for the future.

    During the last two decades, significant progress has been made on global health. For example:

    ODA is one of the key factors behind this success. The 2000s were a golden decade for global health aid, which went from 12 billion dollars in 2000 to almost 35 billion dollars in 2010.

    Today, global health aid seems to have peaked at 37 billion dollars every year, or around a quarter of total aid provided by donor countries.

    Health has long been a priority sector for French aid: almost 1 billion dollars (816 million euros) were dedicated to health in 2016. The Global Fund to Fight Aids, TB and Malaria is the biggest recipient of this funding, receiving almost 360 million euros from France every year, which makes France the second biggest contributor historically to the Global Fund after the USA.

    However, the priority given to global health in French aid now faces competition from other sectors emerging sectors such as education and climate change.

    To learn more about changing global health aid flows, you can download our Policy Note in French here. An English translation of this and other Policy Notes is forthcoming.

    Pour aller plus loin
  • Note d’analyse n°3 : sante et développement, rôle de l’aide publique au développement dans les progrès réalisés
  • À LIRE AUSSI

    - 22 October 2024

    France’s Official Development Assistance in a world of uncertainty: a fading ambition? Review 2017-2024 and outlook

    Where do we stand on the evolution of France's ODA policy since 2017? With figures to back it up, Focus 2030 takes a closer look, at a time when France's ambitions may be coming to an end.
    Sustainable Development Goals - 17 June 2024

    Replenishment of Gavi, the Vaccine Alliance: Vaccinating half of the world’s children

    Gavi, the Vaccine Alliance, intends to mobilize funding for its 2026-2030 strategy. In this special report, you'll find the latest news, facts and figures, campaigns and interviews with experts.
    - 07 May 2024

    Which countries fund global health?

    Focus 2030 analyses the funding promoting access to health in developing countries by industrialised countries, particularly France.
    - 27 July 2023

    Global health: what will be the international milestones in 2023?

    April 7, 2023 marks World Health Day and the 75th anniversary of the WHO. This is an opportunity to take stock of some major news in global health: high-level UN meetings on universal health coverage, pandemic preparedness and the fight against tuberculosis, the Summit for a new global financing pact, the Gavi global conference on immunization, the eradication of polio...
    - 25 May 2022

    International solidarity and France’s role in the world: prospects for the new government

    Overview of the major international conferences of the next five years and the issues that France will have to tackle to contribute to the achievement of the SDGs.
    - 04 April 2022

    Assessment of France’s international development policy during Emmanuel Macron’s five-year term

    How has France's development and international solidarity policy fared during the last five years? Analysis.
    X

    Formulaire d'abonnement à la newsletter de Focus2030

    * indicates required

    Focus 2030 vous transmettra sa newsletter sur l'email fourni dans ce formulaire.

    Je comprends que je peux me désabonner facilement à tout moment en cliquant sur le lien en bas de page de nos lettres d'information. Vos données personnelles collectées resteront strictement confidentielles. Elles ne seront ni vendues ni échangées conformément à nos mentions légales. Pour plus d'informations sur notre politique de confidentialité, consultez notre site web.

    We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices here.